Featured Videos And Webinar Excerpts

  1. The AI Paradox In Clinical Trials 7/17/2026

    AI is advancing the way clinical trial results are analyzed and interpreted. But those advancements still depend on the quality and reliability of the data generated during the trial itself.

  2. When Biological Sample Issues Become Regulatory Review Problems 7/17/2026

    In this video, Dr. Graham explains what led him to look more closely at clinical trial execution and what he uncovered when he mapped the path from sample collection to regulatory submission.

  3. Stop Treating Patient Samples As Acceptable Losses 7/17/2026

    This short webinar excerpt pushes back on the idea that preventable biological sample loss should be tolerated as a routine part of trial execution.

  4. How Sample Issues Can Cause Bioequivalence Studies To Fail 7/17/2026

    In this webinar excerpt, we learn why biological sample issues can have such an outsized impact in bioequivalence studies.

  5. Better Go/No-Go Decisions Start Before The Data Comes In 7/17/2026

    Explore all the reasons that teams should set clear benchmarks before results are reviewed and align the organization on those criteria in advance.

  6. Why Specialty Lab Samples Are So Vulnerable To Trial Execution Errors 7/17/2026

    Biomarkers and other specialty lab samples are among the most fragile parts of clinical trial execution, but what makes them so vulnerable to mishandling, and what are the effects?

  7. What Sponsors Miss About What Patients Need 7/16/2026

    The realities that shape whether patients can participate in a clinical trial are personal, practical, and difficult to see without direct input from the communities being asked to enroll. Explore why sponsors may misunderstand what truly matters to patients and families.

  8. Why Patients Don't Always Tell Sponsors First 7/16/2026

    Patient advocacy groups often hear about clinical trial problems before sponsors ever do. Karsten Baumgaertel explains why, and what that means for how sponsors should be listening.

  9. When Patient Burden Becomes A Retention Risk 7/16/2026

    Patient burden is not theoretical. In this clip, we hear professional insight into why sponsors need to understand patient burden before a trial is underway.